A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

Clinical trial NCT06897930 · RECRUITING

Trial details

NCT number: NCT06897930
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lupus Erythematosus, Systemic

Start date: 2025-04-21
Primary completion: 2029-05-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.